Applied DNA Sciences, Inc.
APDN
$2.98
-$0.28-8.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.30% | -37.19% | -62.07% | -76.76% | -80.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.30% | -37.19% | -62.07% | -76.76% | -80.97% |
| Cost of Revenue | -37.98% | -64.01% | -65.33% | -73.29% | -78.35% |
| Gross Profit | 10.10% | -37.52% | -56.68% | -81.67% | -85.55% |
| SG&A Expenses | -31.44% | -37.31% | -17.08% | -10.56% | -8.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.06% | -17.47% | -26.41% | -29.73% | -33.94% |
| Operating Income | 10.03% | 9.93% | 2.69% | -27.68% | -34.89% |
| Income Before Tax | -30.91% | 66.82% | -17.57% | 29.62% | -4.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.91% | 66.82% | -17.57% | 29.62% | -4.03% |
| Earnings from Discontinued Operations | -894.67% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.83% | -11.24% | -0.30% | 26.22% | 89.96% |
| Net Income | -80.92% | 40.00% | -18.28% | 29.70% | -3.85% |
| EBIT | 10.03% | 9.93% | 2.69% | -27.68% | -34.89% |
| EBITDA | 6.29% | 4.96% | -4.12% | -38.55% | -44.04% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |